156 related articles for article (PubMed ID: 26638436)
1. [Clinical Laboratory Test Using Proteomics: The Usefulness of Proteomic Techniques for Amyloid Typing].
Tasaki M; Obayashi K; Ando Y
Rinsho Byori; 2015 Aug; 63(8):980-5. PubMed ID: 26638436
[TBL] [Abstract][Full Text] [Related]
2. [New Insights into Diagnosis and Pathogenesis of Amyloidosis by Mass Spectrometric Analysis].
Tasaki M; Obayashi K; Ando Y
Rinsho Byori; 2016 Jun; 64(6):675-679. PubMed ID: 30695322
[TBL] [Abstract][Full Text] [Related]
3. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
Tasaki M; Obayashi K; Ueda M; Ando Y
Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
[TBL] [Abstract][Full Text] [Related]
4. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.
Gilbertson JA; Theis JD; Vrana JA; Lachmann H; Wechalekar A; Whelan C; Hawkins PN; Dogan A; Gillmore JD
J Clin Pathol; 2015 Apr; 68(4):314-7. PubMed ID: 25637636
[TBL] [Abstract][Full Text] [Related]
5. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and Clinicopathologic Assessment of Penile Amyloidosis: A Single Institutional Review of 12 Cases.
Tekin B; Gilani SI; Dasari S; Theis JD; Rech KL; Dao LN; Cubilla AL; Herrera Hernandez LP; Jimenez RE; Cheville JC; Dispenzieri A; Howard MT; McPhail ED; Erickson LA; Guo R; Gupta S
Am J Clin Pathol; 2023 Sep; 160(3):303-313. PubMed ID: 37203248
[TBL] [Abstract][Full Text] [Related]
7. Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis.
Theis JD; Dasari S; Vrana JA; Kurtin PJ; Dogan A
J Mass Spectrom; 2013 Oct; 48(10):1067-77. PubMed ID: 24130009
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
[TBL] [Abstract][Full Text] [Related]
9. [Proteomics, a new tool for an accurate typing of amyloidosis].
Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
[TBL] [Abstract][Full Text] [Related]
10. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.
Larsen BT; Mereuta OM; Dasari S; Fayyaz AU; Theis JD; Vrana JA; Grogan M; Dogan A; Dispenzieri A; Edwards WD; Kurtin PJ; Maleszewski JJ
Histopathology; 2016 Apr; 68(5):648-56. PubMed ID: 26212778
[TBL] [Abstract][Full Text] [Related]
11. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
Leung N; Nasr SH; Sethi S
Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
[TBL] [Abstract][Full Text] [Related]
12. Proteomic typing of amyloid deposits in systemic amyloidoses.
Lavatelli F; Vrana JA
Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
[TBL] [Abstract][Full Text] [Related]
13. Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.
Spodzieja M; Rodziewicz-Motowidło S; Szymanska A
Curr Med Chem; 2019; 26(1):104-120. PubMed ID: 28971756
[TBL] [Abstract][Full Text] [Related]
14. Proteomics in molecular diagnosis: typing of amyloidosis.
Loo D; Mollee PN; Renaut P; Hill MM
J Biomed Biotechnol; 2011; 2011():754109. PubMed ID: 22131817
[TBL] [Abstract][Full Text] [Related]
15. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.
Sethi S; Vrana JA; Theis JD; Leung N; Sethi A; Nasr SH; Fervenza FC; Cornell LD; Fidler ME; Dogan A
Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291
[TBL] [Abstract][Full Text] [Related]
16. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
Brambilla F; Lavatelli F; Merlini G; Mauri P
Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
[TBL] [Abstract][Full Text] [Related]
17. Characterization of systemic amyloid deposits by mass spectrometry.
Murphy CL; Wang S; Williams T; Weiss DT; Solomon A
Methods Enzymol; 2006; 412():48-62. PubMed ID: 17046651
[TBL] [Abstract][Full Text] [Related]
18. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
Lavatelli F; Merlini G
Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
[TBL] [Abstract][Full Text] [Related]
19. Proteomics in protein misfolding diseases.
Stoppini M; Obici L; Lavatelli F; Giorgetti S; Marchese L; Moratti R; Bellotti V; Merlini G
Clin Chem Lab Med; 2009; 47(6):627-35. PubMed ID: 19527136
[TBL] [Abstract][Full Text] [Related]
20. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
